Biolife Solutions (BLFS) Total Liabilities (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Total Liabilities of $28.7 million for Q1 2026, down 32.55% year-over-year from $42.5 million in Q1 2025, and down 15.65% quarter-over-quarter from $34.0 million in Q4 2025.
Biolife Solutions (BLFS) Total Liabilities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Total Liabilities for 17 consecutive years, with $28.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 32.55% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (down 32.55% YoY), while the FY2025 annual figure was $34.0 million, down 32.79% from the prior year.
- Total Liabilities retreated to $28.7 million in Q1 2026 per BLFS's latest filing, from $34.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $88.4 million in Q1 2023 and bottomed at $28.7 million in Q1 2026.
- Historically, Total Liabilities has averaged $60.8 million across 5 years, with a median of $61.1 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 118.27% — and 2025, when it tumbled 37.66%.
- Biolife Solutions' Total Liabilities stood at $86.0 million in 2022, then fell by 12.77% to $75.1 million in 2023, then sank by 32.61% to $50.6 million in 2024, then sank by 32.79% to $34.0 million in 2025, then retreated by 15.65% to $28.7 million in 2026.
- Business Quant data shows BLFS's Total Liabilities at $28.7 million in Q1 2026, $34.0 million in Q4 2025, and $38.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 27.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.49 Mn |
| Mar 31, 2026 | 28.68 Mn |
| Dec 31, 2025 | 34.00 Mn |
| Sep 30, 2025 | 38.34 Mn |
| Jun 30, 2025 | 40.09 Mn |
| Mar 31, 2025 | 42.52 Mn |
| Dec 31, 2024 | 50.58 Mn |
| Sep 30, 2024 | 56.19 Mn |
| Jun 30, 2024 | 53.53 Mn |
| Mar 31, 2024 | 68.20 Mn |
| Dec 31, 2023 | 75.05 Mn |
| Sep 30, 2023 | 79.14 Mn |
| Jun 30, 2023 | 81.05 Mn |
| Mar 31, 2023 | 88.36 Mn |
| Dec 31, 2022 | 86.04 Mn |
| Sep 30, 2022 | 82.90 Mn |
| Jun 30, 2022 | 61.14 Mn |
| Mar 31, 2022 | 68.20 Mn |
| Dec 31, 2021 | 76.24 Mn |
| Sep 30, 2021 | 70.13 Mn |